Associate Chief Medical Officer, University of Utah Health Plans Attending Physician - Internal Medicine, Granger Medical Clinic Salt Lake City, UT
Breast cancer is not simply one disease, and the use of more effective therapies that target different tumor markers, such as the cyclin-dependent kinase (CDK)4/6 pathway in estrogen receptor–positive breast cancer, may actually reduce the total cost of care for patients/members and payers.
To sign up for our newsletter or print publications, please enter your contact information below.